Description: Expression of CEACAM1 is associated with the progression of malignancy and metastatic spread in a large array of cancer tissues which include melanoma, Non Small Cell Lung Carcinoma (NSCLC)  bladder, prostate, thyroid, breast, colon and gastric carcinomas. In addition, CEACAM1 has also been identified as receptors for host-specific viruses and bacteria in mice and humans such as Neisseria, Haemophilus influenzae, Moraxella catarrhalis and mouse hepatitis virus (MHV).
 

Purity:  >95% pure estimated by SDS-PAGE (EU Ph. 5.0 § 2.5.31)

Form: Liquid